IL6 and colorectal cancer: Several inflammatory mediators, such as prostaglandins, IL6 (HGNC:6018; interleukin 6), CXCL8 (HGNC:6025; C‐X‐C motif chemokine ligand 8; aka, IL8), IL1A (HGNC:5991; interleukin 1 alpha) and TNF (HGNC:11892; tumor necrosis factor; aka, TNF‐alpha), have been reported to exert tumor‐promoting effects in colorectal cancer through activation of downstream signaling pathways, which may enhance angiogenesis and suppress the anti‐tumor immune response.4